Analysis · beta

Brett Guthrie

Not analysed yet

A requested analysis is usually ready within half an hour; come back to this page or reload it.

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1266, the Combating Illicit Xylazine Act, led by my colleagues Representatives Panetta and Pfluger. Xylazine is a veterinary drug used to sedate large animals. It has no legitimate use in humans, and it is quickly becoming one of the deadliest drugs on our streets. This bill would place xylazine in schedule III of the Controlled Substances Act while ensuring an exemption for appropriate use within the veterinary and ranching industries. The decision to place xylazine in schedule III is a product of extensive bipartisan work spanning two Congresses and two administrations, supported by both DEA and HHS. It is critical that we pass this commonsense bill to strengthen our ability to crack down on illicit xylazine distribution while preserving its legitimate veterinary and ranching uses. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.